Representative before the EPO

Company dna mintz levin cohn ferris glovsky and popeo llp
no operation time available
3 offices
active in Legal Services

Representative before the EPO

Company dna cooley uk llp
no operation time available
2 offices
active in Legal Services

Jacqueline Frances Moore has worked on the following 24 EPO patent applications which have been published in the last five years:

EP11807478

METHOD AND FORMULATIONS FOR TREATING SIALIC ACID DEFICIENCIES

IPC classification:
A61K 9/00, A61K 9/20, A61K 9/22, A61K 31/7012, A61K 47/38, A61P 21/00
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
EXAMINATION IN PROGRESS
EP12725813

PROTEIN HAVING NUCLEASE ACTIVITY, FUSION PROTEINS AND USES THEREOF

IPC classification:
A01K 67/027, C07K 14/415, C12N 15/62, C12N 15/82, C12N 15/85
Applicant:
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH
Agent:
Vossius & Partner Patentanwälte Rechtsanwälte mbB
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP12832060

COMPOSITIONS OF JASMONATE COMPOUNDS AND METHODS OF USE

IPC classification:
A61K 9/14, A61K 9/16, A61K 31/122, A61K 47/30, A61P 29/00, A61P 35/00
Agent:
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Agent:
Multiple attorneys, Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP12843460

SIALIC ACID ANALOGS

IPC classification:
A61K 31/7008, C07H 5/04, C07H 7/02
Agent:
Andrew Jonathan Wills, Mewburn Ellis LLP
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP12846033

PEPTIDES AND METHODS FOR THE DETECTION OF LYME DISEASE ANTIBODIES

IPC classification:
C07K 14/00, G01N 33/53, G01N 33/543
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP12852350

SIGNAL AMPLIFICATION IN LATERAL FLOW AND RELATED IMMUNOASSAYS

IPC classification:
G01N 33/53, G01N 33/543
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP13739040

METHODS AND FORMULATIONS FOR TREATING SIALIC ACID DEFICIENCIES

IPC classification:
A61K 9/20, A61K 9/22, A61K 31/16, A61K 31/195, A61K 31/196, A61K 31/27
Agent:
Andrew Jonathan Wills, Mewburn Ellis LLP
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP12826427

FORMULATIONS OF ACTIVE AGENTS FOR SUSTAINED RELEASE

IPC classification:
A61K 9/00, A61K 38/17, A61K 38/22, A61K 38/26, A61K 38/28, A61M 31/00
Agent:
Robert John Stephen, Olswang LLP
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
EXAMINATION IN PROGRESS
EP13710253

IDENTIFICATION OF CHANNELRHODOPSIN-2 (CHOP2) MUTATIONS AND METHODS OF USE

IPC classification:
C07K 14/705
Applicant:
Wayne State University
Agent:
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Agent:
Multiple attorneys, Cooley (UK) LLP
Status:
EXAMINATION IN PROGRESS
EP13764490

GUERBET ALCOHOLS AND METHODS FOR PREPARING AND USING SAME

IPC classification:
C07C 29/136, C07C 31/125, C07C 45/40, C07C 47/21
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Multiple attorneys, Cooley (UK) LLP
Status:
EXAMINATION IN PROGRESS
EP13712057

FLUORINATED BENZOFURAN DERIVATIVES

IPC classification:
A61K 31/343, A61P 9/00, C07D 307/80
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Multiple attorneys, Cooley (UK) LLP
Status:
EXAMINATION IN PROGRESS
EP13758533

USE OF THYMOSIN ALPHA FOR TREATMENT OF PURULENT RHINOSINUSITIS

IPC classification:
A61K 38/17, A61K 38/22, A61P 11/00
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13784431

FLUORINATED 2-AMINO-4-(BENZYLAMINO)PHENYLCARBAMATE DERIVATIVES

IPC classification:
A61B 8/13, A61K 31/27, A61K 31/44, A61P 25/08, C07C 271/28, C07D 213/75
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Multiple attorneys, Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP13820043

OZONOLYSIS OPERATIONS FOR GENERATION OF REDUCED AND/OR OXIDIZED PRODUCT STREAMS

IPC classification:
C07C 45/40, C07C 47/02, C07C 51/34, C07C 55/18
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Multiple attorneys, Cooley (UK) LLP
Status:
EXAMINATION IN PROGRESS
EP13760222

N-(3-FLUOROBENZYL)-2-(5-(4-MORPHOLINOPHENYL)PYRIDIN-2-YL) ACETAMIDE AS PROTEIN!TYROSINE KINASE MODULATORS

IPC classification:
A61K 31/444, A61P 35/00, A61P 37/00, C07D 213/56
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
EXAMINATION IN PROGRESS
EP13837402

METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF

IPC classification:
A61K 31/50, A61P 3/00, A61P 9/00, C07D 237/16
Applicant:
F. Hoffmann-La Roche Ltd.
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Multiple attorneys, Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP13802822

TREATMENT OF PULMONARY DISEASE

IPC classification:
A61K 31/575, A61P 11/00, A61P 11/06, A61P 11/08, A61P 35/00
Agent:
Deborah Mary Hart, Kilburn & Strode LLP
Agent:
Multiple attorneys, Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP14749249

FLUORINATED INTEGRIN ANTAGONISTS

IPC classification:
A61K 31/4375, A61P 3/10, C07D 471/04
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP14767480

MODULATION OF PLANT IMMUNE SYSTEM FUNCTION

IPC classification:
A01N 65/00, C07K 16/00
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Jacqueline Gail Victoria Evans, Marches Intellectual Property Ltd
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
EXAMINATION REQUESTED
EP14724204

OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF THE EYE

IPC classification:
A61K 9/00, A61K 31/425, A61K 47/40, A61L 15/42, A61L 15/56
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
EXAMINATION REQUESTED
EP14791444

METHODS FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/4406
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Agent:
Gemma Campabadal i Monfà, Wilson Sonsini Goodrich & Rosati LLP (WSGR)
Status:
EXAMINATION REQUESTED
EP15175719

PRECURSOR OF PROPIONYL COENZYME A FOR USE IN THE TREATMENT OF HUNTINGTON DISEASE AND OTHER POLYGLUTAMINE DISEASES

IPC classification:
A61K 31/225
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Cabinet Plasseraud
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
EXAMINATION REQUESTED
EP16182023

SINUS DELIVERY OF SUSTAINED RELEASE THERAPEUTICS

IPC classification:
A61F 13/00, A61K 9/00, A61K 47/34
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
APPLICATION PUBLISHED

Please Sign in to use this feature